Trademark Attorney / Law Firm

J. R. Dimuzio – Trademark Portfolio

J. R. Dimuzio specializes in Class 35 (Advertising & Business) trademark filings before the United States Patent and Trademark Office (USPTO), with 3 of 4 total filings concentrated in this category. The practice also covers Class 13 (Firearms) along with 3 other Nice Classification classes. Filing activity spans from 2018 to 2020. Currently, 3 trademarks are registered.

4 Total Trademarks
Loading...
By Date
By Name
Filter by Class:

Practice Areas by Trademark Class

J. R. Dimuzio's trademark practice covers 3 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.

35
Advertising & Business (3 filings)

Advertising; business management; business administration; office functions

13
Firearms (3 filings)

Firearms; ammunition and projectiles; explosives; fireworks

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademark applications has J. R. Dimuzio filed?

J. R. Dimuzio has filed 4 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 3 registered, 1 abandoned.

What trademark classes does J. R. Dimuzio specialize in?

J. R. Dimuzio has filed trademarks across 3 Nice Classification classes. The most common practice areas include Class 35 (Advertising & Business), Class 13 (Firearms), Class 10 (Medical Apparatus). Class 35 covers advertising; business management; business administration; office functions.

How long has J. R. Dimuzio been filing trademarks?

J. R. Dimuzio's trademark filing history with the USPTO spans from 2018 to 2020, covering 2 years of trademark practice. During this period, J. R. Dimuzio has handled 4 trademark applications.

What is J. R. Dimuzio's trademark registration success rate?

J. R. Dimuzio has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.